EMILY BILLINGS: Open Payments
NPI 1689366056 · ELKIN, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,177 in 72 payments from 18 companies in 2025. Trend: 2023 $0 · 2024 $549 · 2025 $1,177
Food & beverage: $1,177
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 20 | $223 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 14 | $177 |
| Otsuka America Pharmaceutical, Inc. | 6 | $132 |
| Lilly USA, LLC | 4 | $124 |
| AstraZeneca Pharmaceuticals LP | 4 | $75 |
| Novo Nordisk Inc | 4 | $70 |
| Amgen Inc. | 3 | $51 |
| Paratek Pharmaceuticals, Inc. | 3 | $45 |
| GlaxoSmithKline, LLC. | 2 | $44 |
| Phathom Pharmaceuticals, Inc. | 2 | $37 |
Products named: VRAYLAR, CAPLYTA, REXULTI, ZEPBOUND, Ozempic, OTEZLA, TRELEGY ELLIPTA, VOQUEZNA.
Industry payments across NC — which companies pay providers there.
